CIDP (chronic inflammatory demyelinating polyneuropathy) trials in Taiwan

3 of 3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Taking people
  Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Where

  Kaohsiung City, Taipei

  Age

  18 years and over

  People

  201 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT05327114 · EU 2023-508425-28-00
• Phase 3Enrolling by invitation
  Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

  Where

  Taipei

  Age

  18 years and over

  People

  300 worldwide

  Run by

  Sanofi

  See details and how to joinNCT06859099 · EU 2024-517032-22-00
• Phase 3Taking people
  A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Where

  Kaohsiung City, Taipei

  Age

  18 years and over

  People

  160 worldwide

  Run by

  Sanofi

  See details and how to joinNCT06290141 · EU 2023-508338-33-00